180 related articles for article (PubMed ID: 26498851)
1. Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas.
Rodrigo JP; Menéndez ST; Hermida-Prado F; Álvarez-Teijeiro S; Villaronga MÁ; Alonso-Durán L; Vallina A; Martínez-Camblor P; Astudillo A; Suárez C; María García-Pedrero J
Sci Rep; 2015 Oct; 5():15698. PubMed ID: 26498851
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis.
Ruiz C; Martins JR; Rudin F; Schneider S; Dietsche T; Fischer CA; Tornillo L; Terracciano LM; Schreiber R; Bubendorf L; Kunzelmann K
PLoS One; 2012; 7(8):e43265. PubMed ID: 22912841
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
[TBL] [Abstract][Full Text] [Related]
4. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
5. ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer.
Bill A; Gutierrez A; Kulkarni S; Kemp C; Bonenfant D; Voshol H; Duvvuri U; Gaither LA
Oncotarget; 2015 Apr; 6(11):9173-88. PubMed ID: 25823819
[TBL] [Abstract][Full Text] [Related]
6. [Effects of stable ANO1 overexpression on biological behaviors of human laryngeal squamous cell carcinoma Hep-2 cells in vitro].
Li Y; Zhang J; Yang K; Zhang F; Chen R; Chen D
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):251-5. PubMed ID: 24589607
[TBL] [Abstract][Full Text] [Related]
7. ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines.
Ayoub C; Wasylyk C; Li Y; Thomas E; Marisa L; Robé A; Roux M; Abecassis J; de Reyniès A; Wasylyk B
Br J Cancer; 2010 Aug; 103(5):715-26. PubMed ID: 20664600
[TBL] [Abstract][Full Text] [Related]
8. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.
Britschgi A; Bill A; Brinkhaus H; Rothwell C; Clay I; Duss S; Rebhan M; Raman P; Guy CT; Wetzel K; George E; Popa MO; Lilley S; Choudhury H; Gosling M; Wang L; Fitzgerald S; Borawski J; Baffoe J; Labow M; Gaither LA; Bentires-Alj M
Proc Natl Acad Sci U S A; 2013 Mar; 110(11):E1026-34. PubMed ID: 23431153
[TBL] [Abstract][Full Text] [Related]
9. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
[TBL] [Abstract][Full Text] [Related]
10. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.
García-Carracedo D; Villaronga MÁ; Álvarez-Teijeiro S; Hermida-Prado F; Santamaría I; Allonca E; Suárez-Fernández L; Gonzalez MV; Balbín M; Astudillo A; Martínez-Camblor P; Su GH; Rodrigo JP; García-Pedrero JM
Oncotarget; 2016 May; 7(20):29780-93. PubMed ID: 27119232
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation regulates TMEM16A/ANO1 expression through multiple CpG islands in head and neck squamous cell carcinoma.
Finegersh A; Kulich S; Guo T; Favorov AV; Fertig EJ; Danilova LV; Gaykalova DA; Califano JA; Duvvuri U
Sci Rep; 2017 Nov; 7(1):15173. PubMed ID: 29123240
[TBL] [Abstract][Full Text] [Related]
12. ANO1 protein as a potential biomarker for esophageal cancer prognosis and precancerous lesion development prediction.
Shang L; Hao JJ; Zhao XK; He JZ; Shi ZZ; Liu HJ; Wu LF; Jiang YY; Shi F; Yang H; Zhang Y; Liu YZ; Zhang TT; Xu X; Cai Y; Jia XM; Li M; Zhan QM; Li EM; Wang LD; Wei WQ; Wang MR
Oncotarget; 2016 Apr; 7(17):24374-82. PubMed ID: 27016410
[TBL] [Abstract][Full Text] [Related]
13. Role of anoctamins in cancer and apoptosis.
Wanitchakool P; Wolf L; Koehl GE; Sirianant L; Schreiber R; Kulkarni S; Duvvuri U; Kunzelmann K
Philos Trans R Soc Lond B Biol Sci; 2014 Mar; 369(1638):20130096. PubMed ID: 24493744
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
[TBL] [Abstract][Full Text] [Related]
15. Expression of DOG1 (Using SP31) in Poorly Differentiated Carcinoma of the Head and Neck.
Friedrich RE; Wunder T; Schumacher U; Bartel-Friedrich S; Zustin J
Anticancer Res; 2016 Jun; 36(6):3117-22. PubMed ID: 27272836
[TBL] [Abstract][Full Text] [Related]
16. Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients.
Hermida-Prado F; Menéndez ST; Albornoz-Afanasiev P; Granda-Diaz R; Álvarez-Teijeiro S; Villaronga MÁ; Allonca E; Alonso-Durán L; León X; Alemany L; Mena M; Del-Rio-Ibisate N; Astudillo A; Rodríguez R; Rodrigo JP; García-Pedrero JM
J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30513772
[TBL] [Abstract][Full Text] [Related]
17. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
[TBL] [Abstract][Full Text] [Related]
18. Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome.
Muller D; Millon R; Velten M; Bronner G; Jung G; Engelmann A; Flesch H; Eber M; Methlin G; Abecassis J
Eur J Cancer; 1997 Nov; 33(13):2203-10. PubMed ID: 9470807
[TBL] [Abstract][Full Text] [Related]
19. TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation.
Dixit R; Kemp C; Kulich S; Seethala R; Chiosea S; Ling S; Ha PK; Duvvuri U
Sci Rep; 2015 Nov; 5():16657. PubMed ID: 26563938
[TBL] [Abstract][Full Text] [Related]
20. Meta-Analyses of Microarray Datasets Identifies ANO1 and FADD as Prognostic Markers of Head and Neck Cancer.
Reddy RB; Bhat AR; James BL; Govindan SV; Mathew R; Ravindra DR; Hedne N; Illiayaraja J; Kekatpure V; Khora SS; Hicks W; Tata P; Kuriakose MA; Suresh A
PLoS One; 2016; 11(1):e0147409. PubMed ID: 26808319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
